Stephens & Co. Maintains Overweight on Humana, Lowers Price Target to $430
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Scott Fidel has maintained an Overweight rating on Humana (NYSE:HUM) but reduced the price target from $550 to $430.
January 26, 2024 | 6:09 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Stephens & Co. maintains an Overweight rating on Humana but has lowered the price target from $550 to $430, indicating a potential downside compared to the previous target.
The reduction in price target by Stephens & Co. suggests that they see less upside potential for Humana's stock price in the short term. This could lead to a negative investor sentiment and a potential decrease in the stock price as the new target is significantly lower than the previous one.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100